Results 31 to 40 of about 747,888 (257)

Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis

Frontiers in Psychiatry, 2018
Background: The impact of increasing non-medical cannabis use on vulnerability to develop opioid use disorders has received considerable attention, with contrasting findings.
Eduardo R. Butelman, Angelo G. I. Maremmani, Silvia Bacciardi, Carina Y. Chen, Joel Correa da Rosa, Mary Jeanne Kreek   +5 more
doaj   +1 more source

Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study. [PDF]

, 2017
Background: Published evidence indicates that individual use of metformin and statin is associated with reduced cancer mortality. However, their differential and joint effects on pancreatic cancer survival are inconclusive.Methods: We identified a large ...
Demissie, Kitaw, E, Jian-Yu, Graber, Judith M., Lin, Yong, Lu, Shou-En, Lu-Yao, Grace, Petersen, Gloria M., Rotter, David, Tan, Xiang-Lin, Zhang, Lanjing   +9 more
core   +2 more sources

Disordered social media use and risky drinking in young adults: Differential associations with addiction‐linked traits

Australian Journal of Psychology, 2019
Background Excessive or compulsive use of social media has been likened to an addiction, similar to other behavioural addictions such as pathological gambling or Internet addiction.
Michael Lyvers, Shreas S. Narayanan, Fred A. Thorberg   +2 more
doaj   +1 more source

Delineation of dual molecular diagnosis in patients with skeletal deformity

Orphanet Journal of Rare Diseases, 2022
Background Skeletal deformity is characterized by an abnormal anatomical structure of bone and cartilage. In our previous studies, we have found that a substantial proportion of patients with skeletal deformity could be explained by monogenic disorders ...
Lian Liu, Liying Sun, Yujun Chen, Muchuan Wang, Chenxi Yu, Yingzhao Huang, Sen Zhao, Huakang Du, Shaoke Chen, Xin Fan, Wen Tian, Zhihong Wu, Deciphering Disorders Involving Scoliosis and COmorbidities (DISCO) study group, Guixing Qiu, Terry Jianguo Zhang, Nan Wu   +15 more
doaj   +1 more source

Prevalence of Substance Abuse in Patients with Schizophrenia [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Substance abuse is a common comorbidity in patients of Schizophrenia. Link between the use of substances and development of psychosis is demonstrated by high prevalence of substance abuse in schizophrenia.
Parisha Narayan Kelkar, Ganpat K Vankar, Kshirod K Mishra, Sally John, Ajinkya Sureshrao Ghogare   +4 more
doaj   +1 more source

Mental health problems: Are they or are they not a risk factor for dropout from drug treatment? A systematic review of the evidence [PDF]

, 2009
Background: A sizeable number of recent studies investigating whether clients with substance misuse and mental health problems (dual diagnosis clients) are at heightened risk of dropout from drug treatment have been published.
Broome KM, Christine Barrowclough, Crawford V, Goldstein MF, Gossop M, Gossop M, Lewin TJ, Martinez-Raga J, Petra S. Meier, Ross HE, Schulte S   +10 more
core   +1 more source

Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: Results from an open clinical study [PDF]

, 2003
Substance use, especially alcoholism, has been recognized as a significant problem in schizophrenic patients, though only a few studies on the effects of pharmacotherapy in these patients have been conducted so far.
Aichmüller, Claus, Bardeleben, Ulrich von, Beneke, Manfred, Glaser, Thomas, Hornung-Knobel, Sybille, Soyka, Michael, Wegner, Ulrike   +6 more
core   +1 more source

Course of depression symptoms between 3 and 8 months after delivery using two screening tools (EPDS and HSCL-10) on a sample of Sudanese women in Khartoum state

BMC Pregnancy and Childbirth, 2018
Background Effects of depression on parenting and on cognitive development of newborns are augmented when symptoms continue throughout the first postnatal year.
Dina Sami Khalifa, Kari Glavin, Espen Bjertness, Lars Lien   +3 more
doaj   +1 more source

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

Drugs - Real World Outcomes, 2020
Aim To evaluate the efficacy and impact of long-acting injectable (LAI) aripiprazole in patients with schizophrenia with a coexisting substance use disorder (SUD). Patients and methods A multicenter, observational, descriptive and retrospective study was
Nestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, Jose Martinez-Raga, Carlos Parro-Torres, Julia Cambra Almerge, Lara Grau-López, Mario De Matteis, Francisco Arias   +8 more
doaj   +1 more source

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study

Drugs - Real World Outcomes, 2020
A randomized, 1-year follow-up study comparing LAI aripiprazole with LAI paliperidone in patients with psychosis, mostly schizophrenia, and SUD reported a large effect of the change from baseline in the CGI severity score, from 5.9 to 2.4 for LAI ...
Nestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, Jose Martinez-Raga, Carlos Parro-Torres, Julia Cambra Almerge, Lara Grau-López, Mario De Matteis, Francisco Arias   +8 more
doaj   +1 more source